Current and future therapy in Alzheimer's disease

被引：99

作者：

van Marum, Robert J. ^{[1
]}

机构：

[1] Univ Utrecht, Med Ctr, Dept Geriatr, NL-3500 GA Utrecht, Netherlands

来源：

FUNDAMENTAL & CLINICAL PHARMACOLOGY | 2008年 / 22卷 / 03期

关键词：

alzheimer's disease; amyloid hypothesis; dementia; drug therapy;

D O I：

10.1111/j.1472-8206.2008.00578.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Dementia is increasingly being recognized as one of the most important medical problems in the elderly. As most pharmacological research within the field of dementia is focused on Alzheimer's dementia (AD), this review will focus on pharmacological interventions in AD. Most disease-modifying therapies are based on the amyloid hypothesis. In this hypothesis, the pathological accumulation of A beta in the brain leads to oxidative stress, neuronal destruction and finally the clinical syndrome of AD. Following this hypothesis, secondary prevention of AD can be made by: decreasing the production of A beta, stimulation of clearance of A beta formed or prevention of aggregation of A beta into amyloid plaques. First a short overview on current approved therapies for AD is given. The main part of the review will focus on potential disease-modifying therapies for AD that are currently being studied in phase I to phase III trials.

引用

页码：265 / 274

页数：10

共 68 条

[1] A Phase II study targeting amyloid-β with 3APS in mild-to-moderate Alzheimer disease [J].

Aisen, P. S. ;

Saumier, D. ;

Briand, R. ;

Laurin, J. ;

Gervais, F. ;

Tremblay, P. ;

Garceau, D. .

NEUROLOGY, 2006, 67 (10) :1757-1763

[2]

[Anonymous], ALZHEIMERS DEMENT S1

[3]

Bachurin S, 2001, ANN NY ACAD SCI, V939, P425

[4] The K variant of the butyrylcholinesterase gene is associated with reduced phosphorylation of tau in dementia patients [J].

Ballard, C ;

Morris, C ;

Kalaria, R ;

McKeith, I ;

Perry, R ;

Perry, E .

DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2005, 19 (5-6) :357-360

[5] Cholinesterase inhibitors for Alzheimer's disease [J].

Birks, J .

COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2006, (01)

[6] Differential modulation of Alzheimer's disease amyloid β-peptide accumulation by diverse classes of metal ligands [J].

Caragounis, Aphrodite ;

Du, Tai ;

Filiz, Gulay ;

Laughton, Katrina M. ;

Volitakis, Irene ;

Sharples, Robyn A. ;

Cherny, Robert A. ;

Masters, Colin L. ;

Drew, Simon C. ;

Hill, Andrew F. ;

Li, Qiao-Xin ;

Crouch, Peter J. ;

Barnham, Kevin J. ;

White, Anthony R. .

BIOCHEMICAL JOURNAL, 2007, 407 :435-450

[7]

Chohan MO, 2006, J ALZHEIMERS DIS, V10, P81

[8] RAGE (Yin) versus LRP (Yang) balance regulates Alzheimer amyloid β-peptide clearance through transport across the blood-brain barrier [J].

Deane, R ;

Wu, ZH ;

Zlokovic, BV .

STROKE, 2004, 35 (11) :2628-2631

[9] RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain [J].

Deane, R ;

Yan, SD ;

Submamaryan, RK ;

LaRue, B ;

Jovanovic, S ;

Hogg, E ;

Welch, D ;

Manness, L ;

Lin, C ;

Yu, J ;

Zhu, H ;

Ghiso, J ;

Frangione, B ;

Stern, A ;

Schmidt, AM ;

Armstrong, DL ;

Arnold, B ;

Liliensiek, B ;

Nawroth, P ;

Hofman, F ;

Kindy, M ;

Stern, D ;

Zlokovic, B .

NATURE MEDICINE, 2003, 9 (07) :907-913

[10] Role of the blood-brain barrier in the pathogenesis of Alzheimer's disease [J].

Deane, Rashid ;

Zlokovic, Berislav V. .

CURRENT ALZHEIMER RESEARCH, 2007, 4 (02) :191-197

← 1 2 3 4 5 6 7 →